Gene: PTAR1
Official Full Name: protein prenyltransferase alpha subunit repeat containing 1provided by HGNC
Gene Summary: Predicted to enable protein prenyltransferase activity. Predicted to contribute to Rab geranylgeranyltransferase activity. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14811 | PTAR1 Knockout cell line (HeLa) | Human | PTAR1 | 1:3~1:6 | Negative | Online Inquiry |
KO14812 | PTAR1 Knockout cell line (HCT 116) | Human | PTAR1 | 1:2~1:4 | Negative | Online Inquiry |
KO14813 | PTAR1 Knockout cell line (HEK293) | Human | PTAR1 | 1:3~1:6 | Negative | Online Inquiry |
KO14814 | PTAR1 Knockout cell line (A549) | Human | PTAR1 | 1:3~1:4 | Negative | Online Inquiry |
PTAR1 Gene Knockout Cell Lines are specialized cell cultures developed to provide researchers with a powerful tool for studying the PTAR1 gene's functions and its implications in various biological processes. These knockout cell lines are generated through precise genomic editing techniques, such as CRISPR/Cas9, effectively disrupting the PTAR1 gene's coding sequence. This allows for the investigation of gene knockout effects on cellular behavior, signaling pathways, and interactions, enabling researchers to elucidate the role of PTAR1 in health and disease.
The primary function of PTAR1 Gene Knockout Cell Lines lies in their ability to simulate a loss-of-function mutation, providing insights into the PTAR1 gene's contributions to cellular processes such as proliferation, differentiation, and apoptosis. By observing the phenotypic changes in these knockout cell lines, scientists can uncover the gene's involvement in various physiological and pathological contexts, including cancer progression and metabolic disorders.
In terms of scientific importance, PTAR1 Gene Knockout Cell Lines serve as a valuable model in both research and clinical settings, facilitating the screening of potential therapeutics and the identification of biomarkers relevant to diseases associated with PTAR1 dysfunction. This makes them an indispensable resource for researchers aiming to advance our understanding of molecular mechanisms and to drive innovative therapeutic strategies.
One of the key advantages of our PTAR1 Gene Knockout Cell Lines is their reliability and reproducibility, attributes that are critical for obtaining robust experimental data. Additionally, these lines are backed by thorough validation processes, ensuring that the gene knockout is confirmed and characterized, which is essential for confident applications in downstream experiments. Compared to alternative models, our cell lines offer superior versatility, allowing for various applications, including drug screening, gene expression analysis, and functional assays.
For researchers and clinicians seeking to deepen their knowledge of gene function or explore new therapeutic avenues, PTAR1 Gene Knockout Cell Lines present an invaluable opportunity. Their comprehensive capabilities and rigorous development make them a noteworthy addition to any laboratory focused on genetic research.
Our company is dedicated to advancing biological research through high-quality, scientifically-validated products, and we take pride in our expertise in cell line development that supports innovative studies and breakthroughs in the biomedical field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.